Skip to main content

Table 3 Toxicity

From: Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients

 

Grade 1

Grade 2

Grade 3

Grade 4

Performance status

1

4

1

 

Fatigue

2

3

1

 

Leucopenia

   

6

Neutropenia

   

6

Lymphopenia

   

6

Thrombopenia

  

2

1

Anemia

 

6

  

Nausea

1

4

  

Diarrhea

2

2

1

 

Vomiting

2

 

1

 

Infections

2

 

1

 

Alopecia

 

6

  

Dermatitis

2

1

  

Allergic reaction

3

   

Low sodium levels

2

 

3

1

  1. No grade 3–4 events were associated with Interleukin-2 treatment. Grade is referring to Common Terminology Criteria for Adverse Events (CTCAE) v. 3.0. Digits in the table are referring to number of patients with the given adverse event.
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us